EUVIMEDEUVIMED entdecken
Crossref

One Bad Apple Can Spoil the Bunch: The Impact of Contamination in the Clinical Laboratory

Hannah Marie Brown, Christopher W Farnsworth, Andrew Bryan, Jonathan R Genzen, Ann Gronowski, Jamie Philips Deeter, Melanie Yarbrough iD

Clinical Chemistry · 2023

DOI: 10.1093/clinchem/hvac182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, 2023. Verfasst von Hannah Marie Brown und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Chemistry Fellow, Department of Pathology & Immunology, Washington University in St. Louis, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Clinical Laboratory Services, Laboratories, Clinical. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Laboratory contamination is a relatively broad, diverse, and often overlooked concern in the clinical laboratory. All clinical specimens have the potential to harbor infectious disease such as HIV and pose a potential risk to laboratory workers. However, the term “laboratory contamination” also encompasses the potential impact of the laboratory on the analysis of a specimen. For example, contamination may be introduced by laboratory staff or from carryover from another specimen. As a result, laboratory contamination may have serious and widespread negative impacts on both diagnostic testing and laboratory staff. With regards to testing, if not identified early, the impacts can extend far beyond an individual patient’s sample, possibly jeopardizing the integrity of a multitude of patient samples and instruments. Despite routine quality control (QC) procedures, the number and types of contamination events in the clinical laboratory are unknown and generally not reported. Further, investigation into the source of contamination can be time and cost intensive, involving methods such as precision studies, instrument service and replacement of parts, airflow analysis, assessing water purification systems, environmental dust sampling, and development of methods for monitoring and cleaning. Measures to decontaminate the laboratory and impacted equipment are both cost and labor intensive. Despite this, there is limited data in the available literature regarding procedures for effective decontamination. Confidently and consistently detecting, verifying, and addressing contamination is critical in clinical laboratories. In this Q&A article, leading experts in clinical chemistry, microbiology, molecular genetic pathology, and infectious disease discuss the impacts of contamination in the clinical laboratory, including effective methods to identify sources of contamination and preventative measures that can be implemented. Andrew Bryan: At its most basic level, contamination in the laboratory means something is where you don’t want it to be with the potential for an adverse outcome—even if that just means a few more minutes of cleaning. Functionally, I’d break it down into analytic/preanalytic risks and risks to our staff, as outlined earlier. On the analytic/preanalytic front, I’m most worried about our nucleicacid amplification tests (NAATs), particularly those performed in core laboratories or otherwise by nonspecialized testing personnel for infectious agents that can reach high titers. Intravenous line contamination at blood draw can also be a big issue in chemistry and coagulation. While still incredibly challenging, I think we have a better framework and more concrete tools on analytic fronts, including routine negative QC, individualized quality control plans (IQCP), delta checks, ability to apply robust statistical approaches, etc. Jonathan R. Genzen: In a clinical laboratory, I would define contamination as the presence of a substance in a location that could interfere with analytical testing or that could jeopardize the health and safety of either patients or employees. It’s a very broad concept and could include pathogens, DNA/RNA, reagents, water supplies, specimens, and even substances not normally considered such as dust. Ann Gronowski: In the context of the laboratory, I think of contamination as “something that shouldn’t be there.” Contamination can be physical (foreign particles), chemical (nonliving substance), or biological (bacterial, viral, molds, yeast). As a result of the contamination, either samples are unsuitable for testing or may give incorrect results or the contamination may make conditions unsafe for lab workers. Things that can make samples unsuitable for testing include: fibers, plastics, hair, IV fluids, exogenous source of molecules (e.g., drugs, amplified DNA, etc.). Things that can make conditions unsafe for workers include infectious agents, radioactive materials, other hazardous agents that can be inhaled or absorbed. Melanie Yarbrough: As a clinical microbiologist, I typically think about contamination in terms of spurious introduction of a microorganism or nucleic acid from a microorganism into laboratory reagents or clinical specimens and cultures. Microbiological contamination may be defined as accidental introduction of infectious material, from another patient specimen or from the environment, that can lead to a false positive result. Culture media and laboratory reagents may be contaminated with live microorganisms in the course of processing or handling reagents if sterile technique is not properly used. Cross-contamination may occur if equipment or instrumentation is contaminated with patient specimens or microorganisms during specimen processing and inoculation of plated media or while making slides, handling culture plates, or setting up antimicrobial susceptibility testing. This may lead to false reporting of microorganism growth from clinical cultures, which is especially worrisome for sterile body fluids and tissue specimens for which growth of even one colony of bacteria may be significant. Jamie Philips Deeter: Contamination is undesired introduction of impurities like chemical, microbial, or physical matter into a patient sample while processing, storing, transferring, packaging, and/or transporting. It can be divided into 3 main categories: environmental, chemical, and physical. All possible sources of contamination should be considered with the utmost importance to ensure patient results integrity. Jamie Philips Deeter: The impact of contamination on patient care and healthcare workers must be mitigated as it can lead to false-positive or false-negative results that cause mismanagement, as well as exposure of workers to risk. Andrew Bryan: Overall, I think we do a relatively good job of limiting the impact to patients and staff, but, of course, the consequences can be catastrophic, using the extreme examples of laboratory-acquired hemorrhagic fever viruses or HIV. I suspect the most common scenario is a false positive NAAT result from a respiratory or gastrointestinal pathogen leading to an incorrect clinical diagnosis and potential unnecessary treatment or quarantine. While still taking both seriously, we tend to consider false-positive results leading to treatment changes as slightly less impactful than false negative results, e.g., “very major” vs “major” errors in antimicrobial susceptibility testing. It’s important to keep in mind, however, that a false positive result could prevent someone from saying goodbye to a dying loved one, a parent from welcoming a newborn into the world, or unpaid loss of work that can have unequal impacts across populations. The risks to our staff from infectious diseases is what haunts me the most, particularly when we start talking about high-consequence pathogens. In the laboratory community, we are less well trained with concepts of occupational health than robust analytic methods, yet, as a CLIA director, I am just as responsible for safety of our staff as for an accurate test result required for safe patient care. I suspect the most common impact to staff from the laboratory-acquired infection standpoint is from common respiratory viruses and bacterial or viral gastrointestinal pathogens—we just don’t recognize it very well because we can’t distinguish it from community acquisition or fail to investigate. We probably do a better job with bloodborne pathogen exposures or high-consequence pathogens because there is typically more investigation and follow-up. The most common impact to staff from contamination? Probably the extra time and frustration problem-solving and cleaning. It can be infuriating to have repeated false positives from presumptive contamination and not know where it is coming from. Melanie Yarbrough: Contamination events in microbiologic testing can lead to false diagnosis of an infectious disease or even pseudo-outbreaks that prompt investigations by infection control within a hospital. This can lead to inappropriate antimicrobial treatment for patients, drug toxicity, increased time in the hospital, and increased hospital costs. Furthermore, this may lead to a failure to find the true cause of a patient’s symptoms if additional testing or other studies are stopped as a result of the false diagnosis. For laboratory staff, contamination may lead to unnecessary workup of microbiology cultures, including additional unneeded downstream testing such as antimicrobial susceptibility testing (AST). Suspected contamination events lead to investigations to discover the source of contamination and the need for documentation around mitigation and prevention measures. Staff may need to undergo additional training and practice in the use of personal protective equipment (PPE) and appropriate decontamination measures for both immediate contamination response and routine cleaning to prevent future events. Jonathan R. Genzen: In general, contamination can have a negative impact in one of 2 ways—direct/indirect exposure to a person or impact on analytical results. These are not mutually exclusive. Direct exposure of a contaminant to a laboratory worker could be from a leaked specimen (e.g., SARS-CoV-2 virus in a respiratory specimen, a leaking biowaste container, or a spilled reagent that is biohazardous). Direct exposures also include splashes, skin punctures, or inhalation of infectious organisms. The COVID-19 pandemic has led to a much greater emphasis on respiratory protection and face shields in clinical laboratory settings, as well as the recognition of the value of all forms of PPE in protecting the workforce from direct contamination. It has also highlighted risks of indirect exposures to fomites—physical objects that may become contaminated if, for example, they are touched by one worker wearing contaminated gloves and then touched later by another individual who is not wearing gloves. The second aspect of contamination—impact on analytical testing—can affect a laboratory’s ability to provide accurate results and has profound implications for patient care if not recognized and mitigated promptly. There are other contamination risks within clinical laboratories that are also important but that don’t get the same attention or visibility regarding risk. For example, spillage of a critical reagent (e.g., a high calibrator) near sensitive instrumentation could impact analytical results. Construction activities or environmental contamination (e.g., tracking of dirt from shoes) pose a risk for contamination in laboratories that perform trace element testing. We’ve also described risks of analytical contamination by topical therapeutics (i.e., pharmaceutical creams) with instruments that perform testing for these drugs. Ann Gronowski: I think that laboratorians are most familiar with things from the environment or lab worker that can contaminate biological specimens and make them unsuitable for testing. However, we could probably spend more time thinking about contamination from the environment or specimens that may affect laboratory workers, things like infectious, radioactive, and chemical contamination. The impact of contamination can be huge. It can result in incorrect lab measurements, which can lead to incorrect diagnoses and treatment. Contamination can also lead to sick or injured lab workers. It is likely that we do not fully appreciate the total impact of “contamination” on healthcare quality and cost. Ann Gronowski: Monitoring contamination in the analytical process can be achieved through QC, delta checks, and environmental monitoring. Monitoring contamination of lab workers is more difficult. Work-related injuries and (some) illnesses are monitored by occupational health in many US facilities. However, most clinical laboratories do not monitor infections or radioactive exposure in their workers. Therefore true lab-acquired infection rates and cumulative radioactivity exposure is not really known. Standardized processes for investigating and reporting all laboratory acquired infections should be developed. Air quality is another understudied environmental factor that likely affects laboratory workers’ health. While there are regulations about minimum number of air exchanges per hour in different laboratory settings, these do not take into account number of people per square foot. Jonathan R. Genzen: Recognition of contamination risk varies across different laboratory disciplines, as do the tools to identify and monitor it. Swab testing of surfaces is relatively common in molecular laboratories to monitor for contamination and mitigate concerns. Checkerboard contamination tests (alternating positive and negative specimens in 96- or 384-well plates) can also facilitate assessment of potential carryover within automated analytical instrumentation or liquid handlers. This can also be helpful with mass spectrometry assays that measure drugs across wide concentration ranges. Methods for identification and monitoring are not well described in many other settings. In our own experience, we’ve created our own sampling methods (when appropriate) based on approaches used in molecular surveillance or the field of environmental testing. The to testing should be the at (i.e., is there a is there not a and probably need to be on critical for or safety is the with which monitoring should be This based on potential risk to patient testing or health. Jamie Philips Deeter: to the concern of contamination, a risk assessment for handling infectious specimens is critical to ensure the safety of laboratory workers. for monitoring environmental contamination is testing performed at a positive result from testing the presence of environmental and/or contamination and should be by a quality on cleaning a are in the and should be procedures for monitoring false positives and of testing, quality and cleaning and methods, can for Monitoring in the of by the of The for quality monitoring by are not just for instrumentation and can be for within a Melanie Yarbrough: The clinical microbiology laboratory a of to contamination events. are in many of the laboratory, such as direct microbiologic to monitor for reagent contamination. of culture media should be to use to ensure media integrity and and of used for should be by the used for of contamination on microbiologic is as the result for many is growth of an However, of an may be a of contamination. it is helpful to be of in growth of or from specimen types as a for a potential contamination For example, of an environmental in sterile specimens or on one of media may be a of contamination. For laboratories molecular infectious disease testing, a of environmental monitoring of laboratory surfaces and instruments should be to spurious contamination of nucleic from positive results are another for of contamination. results should be to of the results in Andrew Bryan: contamination and contamination from pathogens can be relatively to particularly when a negative control is The big is when contamination is and level, often even if there is a The risk of contamination of and NAAT test performed in core laboratories and it can be particularly may the of staff that are less trained in molecular and by other testing sensitive including that may a positive result with a value as high as that do not have or not the the pathogens with high community that make it to clinical to clinical (e.g., per an to biological safety in core laboratories. We generally think of test as particularly systems, but it may be that contamination is just a to than in tests performed in molecular laboratories. would be for to include for results for contamination that could both value and statistical of when a result is more than for the Jamie Philips Deeter: preventative measures include monitoring for contamination, decontamination and equipment that is to the of contamination result integrity. clinical laboratories total laboratory and to ensure in sample result and integrity by including physical and chemical into the testing by the include and with that a environment within the testing other physical that have are and of the that the amplified Further, liquid handling in many are an additional that from contamination. This is and monitoring to the of the of time sample or sample within the For systems, testing liquid handling with a sample give but often with a wide of It is critical to the risk of contamination for samples of high and perform these tests and include the data in the In to the physical to contamination, include chemical such as an that is in the of The presence of this in the the risk of false-positive results from carryover contamination by amplification from molecules and the need for decontamination with who have to are the same from as they from the laboratory. With the introduction of sensitive molecular that can be performed to the patient in settings, there is concern regarding contamination of instrumentation to when processing, or environmental contamination. Jonathan R. Genzen: and procedures regarding the importance of a laboratory and appropriate use of PPE are the most important cleaning and decontamination for are in molecular testing but less robust in automated and testing settings. our with events as and laboratory and surfaces them much to and more work processes that is less to I think a also something about events to be if you can get the to equipment and that Melanie Yarbrough: contamination it is important to the contamination to such as use of systems, and to are good to of should that prevent microbiologic testing on specimens that by a sampling that specimens with one or or that of a the laboratory molecular testing on samples that using automated the lab should perform a risk including carryover studies or an of the to the risk for contamination of downstream samples using automated microbiologic testing should be one at a a processing specimens for sensitive testing such as it is practice to gloves specimen to prevent These are of laboratory who should a culture of laboratory and make that staff are appropriate time to cleaning and mitigation to ensure with to prevent contamination. Ann Gronowski: use of personal protective lab face and face shields when appropriate) can workers and specimens from the use of can be of lab processes can prevent errors and time of exposure to and from agents can also prevent exposure to Overall, the laboratory should be well and and the use of should be or of should be or We need to provide better and especially in risk to clinical and diagnostic laboratories. Andrew Bryan: the time to do a risk assessment and staff their routine clinical including during of and high test of the that we from during the for blood of the from the on the do it within the At the risk of the a of gloves is but of and with risks of contamination in is also have to make it to do the I have a a in a microbiology lab but often have to around in other laboratories to find a up when you at risk for contamination can have a I still a at a during a health and for not the and to on gloves to start a culture where to up can take a of Jonathan R. Genzen: of contamination can be incredibly and prevention and recognition are The core for are the same for clinical laboratories as they are in or environmental In of cost and to these are a In all all clinical laboratory contamination events can be in the with robust cleaning as well as of impacted The appropriate cleaning based on the contaminant and For example, may be appropriate for decontamination with but they would have on contamination with of a on the of contamination, the impact of cleaning (e.g., can also affect ability to with personnel in the of many the risk of contamination by or that would otherwise be to Melanie Yarbrough: The and of the contamination appropriate processes for decontamination. the source of the contamination is

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Laboratory ServicesLaboratories, ClinicalHumansChemistry, Analytic

Autor:innen und Institutionen

  • Clinical Chemistry Fellow, Department of Pathology & Immunology, Washington University in St. Louis, St. Louis, MO, USA.
  • Associate Professor, Department of Pathology & Immunology, Washington University in St. Louis, St. Louis, MO, USA.
  • Assistant Professor, Assistant Director of Clinical Microbiology, Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, USA.
  • Professor (Clinical), Department of Pathology, University of Utah Health and Chief Medical Officer, ARUP Laboratories, Salt Lake City, UT, USA.
  • Professor, Division Chief of Laboratory and Genomics Medicine, Washington University in St. Louis, St. Louis, MO, USA.
  • Medical and Scientific Affairs, Roche Diagnostics Corporation, Indianapolis, IN, USA.

ORCID-Profile: Melanie Yarbrough

Zitieren

APA

Brown, H. M., Farnsworth, C. W., Bryan, A., Genzen, J. R., Gronowski, A., Philips Deeter, J., & Yarbrough, M. (2023). One Bad Apple Can Spoil the Bunch: The Impact of Contamination in the Clinical Laboratory. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvac182

Vancouver

Brown HM, Farnsworth CW, Bryan A, Genzen JR, Gronowski A, Philips Deeter J, et al. One Bad Apple Can Spoil the Bunch: The Impact of Contamination in the Clinical Laboratory. Clinical Chemistry. 2023. doi:10.1093/clinchem/hvac182

BibTeX
@article{Brown2023,
  author = {Brown, Hannah Marie and Farnsworth, Christopher W and Bryan, Andrew and Genzen, Jonathan R and Gronowski, Ann and Philips Deeter, Jamie and Yarbrough, Melanie},
  title = {One Bad Apple Can Spoil the Bunch: The Impact of Contamination in the Clinical Laboratory},
  journal = {Clinical Chemistry},
  year = {2023},
  doi = {10.1093/clinchem/hvac182}
}
Kostenlos starten →